THE POWER OF MOLECULAR (PCR) TESTING
Improved clinical diagnostics and treatment compared to traditional cultures
OUR MOLECULAR (PCR) TESTS
URINARY TRACT INFECTION
Urinary Tract Infections can cause frequent hospitalizations, especially in chronic or hard-to-treat infections. Our molecular PCR testing quickly identifies the pathogen(s), including those often missed in cultures, and the antibiotic resistance markers. These critical results are delivered in under 24 hours. This test can be reflexed to traditional culture for antibiotic sensitivities.
Skin and soft tissue infections can quickly progress causing further damage to the tissue as well as additional pain and discomfort to your patient. Our molecular wound test identifies the infection-causing pathogen(s) as well as the antibiotic resistance markers in less than 24 hours to allow you to quickly and confidently choose the best treatment for your patient.
Bacterial vaginosis and yeast-caused vaginitis are the top two most common causes of vaginal infections. The prevalence of BV in the US is estimated to be 21.2 million (almost 30%) among women ages 14-49. An estimated 1.4 million outpatient visits for vaginal candidiasis occur annually in the US, according to CDC data. Our molecular PCR testing for women’s health provides rapid and definitive results that lead to effective treatments for BV and VC infections.
According to the CDC's most recent analyses, 1 in 5 people in the US had an STI in 2018. Many of these infections go undetected because they have no symptoms but can cause serious health consequences, especially if left untreated. STI testing is critical in the prevention of disease transmission. Our molecular STI test panel covers the most common causes of these infections and provides results in less than 24 hours for prompt effective treatment decisions.